The New Non-Addictive Morphine?
With the opioid epidemic continuing to march full speed ahead, stakeholders are mounting pressure to help curb the impact. The clinical community is taking aim at reducing the practice of overprescribing and medical schools now focus on addiction prevention. And, the research community is also working on a pharmacological approach – developing cutting edge pain relievers that don’t have the negative side effects like nausea, respiratory depression and addiction. There are currently several new compounds under development that hope to deliver the same opioid level of relief but without the hefty health risks. One experimental synthetic opioid, UMB425, has proven, thus far, to deliver promising results. Researchers at the University of Maryland at Baltimore have been working on developing painkillers on par with OxyContin and Percocet, but without the addictive qualities of those drugs. “We designed this so that when you discontinue the drug, the patient doesn’t go into withdrawal sympto...